Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy
up to 40% of patients progressing toward end stage renal failure after 10 years. 5 Researches into the molecular mechanisms underlying the pathogenesis of MN were focused many years ago on the identification of target antigens, which initiate the formation of the immune complex. The generation of an experimental model of MN established in rats by Heymann and coworkers fifty years ago, represents the start-point of pathophysiological researches on MN. 6 Active (AHN) and passive type Heymann (PHN) nephritis were induced by direct immunization of Lewis rats with crude preparation of brush border proteins or by injection of rabbit anti-rat brush border antibodies, respectively. Both AHN and PHN closely mimic the human glomerular disease. 7 The identification in this model of the target antigen, megalin, a common component of the tubular and glomerular epithelial cell provided the molecular basis of podocyte disease in MN. 8, 9 Nevertheless, since human podocytes do not express megalin, it cannot be considered as the target antigen in human MN. 1 In the last decades, many studies have focused on the identification of the antigen involved in human MN. Several antigens involved in secondary mother. In this form of MN, the membrane attack of complement (C5b-9) was also detected within the immune deposits, which indicated that like anti-megalin antibodies, anti-NEP could induce complement activation potentially leading to podocyte injury. 11, 12 Subsequently, Beck et al reported that about 70% of patients with idiopathic MN have autoantibodies that react with the M-type phospholipase A2 receptor (PLA2-R), a glycoprotein constitutively expressed in podocytes. 3 Prunotto et al. identified two additional targets of autoimmunity, aldoreductase and SOD2, both induced in glomeruli of patients with MN. 4 The onset of proteinuria during the course of MN is associated with phenotypic alteration of podocyte and slit diaphragm integrity as demonstrated in a Heymann nephritis model. [13] [14] [15] The abundance of nephrin, a major protein of slit diaphragm, is reduced in PHN and in biopsies from patients with MN, while the mRNA and protein expression of cation permeable ion channel TRPC6, which is mutated in the familial form of focal segmental glomerulosclerosis, 16 is increased. 13-15, 17, 18 However, the mechanisms that lead to these alterations remain partly obscure
The membrane attack complex of complement C5b-9/Mac is thought to play a crucial role in the induction of podocyte injury leading to proteinuria in this model. 12, 19 In PHN, proteinuria has been suggested to be entirely dependent on C5b-9/Mac. 20 These data have recently been challenged by the finding that AHN and PHN can be induced in rat deficient in complement component C6, which is unable to form Mac. 21, 22 Indeed, in PVG/C6 -/-rats, the degree of proteinuria, the extent of cellular infiltrates, the abundance of Ig, C3 and electron-dense deposits were similar to those observed in the PVG/c rats. 22 Anti-podocyte antibodies including antimegalin, anti-NEP and anti-PLA2-R are directed against functional receptor or enzymatic proteins, so that their binding may induce a cascade of events that may directly alter podocyte biology. 23 In the wake of studies aimed to understand the molecular pathophysiology of idiopathic nephrotic syndrome, we identified a new gene, c-mip (for c-maf inducing protein), which encodes an 86-kDa protein. 24 The predicted structure of c-mip includes an N-terminal region 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Results

Renal expression of c-mip in membranous nephropathy and passive Heymann Nephritis
Northern blot analysis showed that basal expression of c-mip in podocyte was scarcely or below the detection limits in control human kidneys (Figure 1a ), which suggests that c-mip is transcriptionally repressed in physiological situations. However, quantitative PCR from laser microdissected glomeruli from five control samples and eleven MN biopsy specimens showed that c-mip abundance was significantly increased in MN (Figure 1b ). In addition, we confirmed by in situ hybridization (Figure 1c ), confocal immunofluorescence ( Figure 1d ) and immunohistochemistry analysis (supplementary Figure S1 ) that c-mip was overproduced at the mRNA and protein levels in patients with MN.
The finding that c-mip was highly induced in podocytes of patients with MN led us to study its expression 
Overexpression of c-mip induces phenotypical and biochemical alterations
To understand the effects of c-mip on podocyte function in PHN, we established stably transfected podocyte cell lines using the inducible T Rex system. Stable c-mip-overexpressing cells exhibited abnormal morphology with retraction of cell body, loss of stress fibers and were more susceptible to cell Figure   S2 ). The abundance of synaptopodin, a regulator of podocyte actin cytoskeleton reorganization, was decreased ( Figure 3b) . Interestingly, the abundance of synaptopodin was reduced in MN glomeruli and in c-mip transgenic mice (Figure 3c ).
Because RhoA is required for actin stress fiber formation by interacting notably with synaptopodin, 26 we investigated RhoA activity in stably c-mip-transfected cells. In the absence of tetracycline, RhoA activity was increased in stably transfected podocytes (Figure 4a ). However, tetracycline treatment was associated with lower RhoA activity (Figure 4a ), but has no effect on Cdc42 activity (Figure 4b ), while c-mip was clearly induced (Figure 4c ). Tetracycline treatment did not seem to have any influence on RhoA activity in wild-type podocytes ( Figure 4d ).
The observation that c-mip alters the adhesion of cultured podocytes to collagen matrix led us to explore whether c-mip affects the abundance of integrin linked kinase (ILK), an adhesion-associated kinase, whose upregulation was shown to cause podocyte detachment. 27, 28 Low ILK expression was found in non-induced podocytes, whereas following tetracycline treatment stable c-mip-overexpressing cells exhibited increased ILK levels but podocin abundance did not significantly change (Figure 5a ).
Because cell detachment from the extracellular matrix alters matrix-transduced survival pathways and cytoskeleton architecture, resulting in release of proapoptotic factors, 29 we tested whether c-mip affects the expression of death-associated protein kinase (DAPK), an actin filament-associated proapoptotic protein. 30 Immunoblotting revealed that podocytes expressing c-mip exhibited higher abundance of DAPK ( Figure 5a ). The relevance of these findings was tested in vivo both in transgenic mice and PHN rats. Western blot analysis of glomerular lysates showed that c-mip transgenic mice exhibited an increased abundance of DAPK and ILK in c-mip transgenic mice, without significantly change in podocine expression ( Figure 5b ). Moreover, increased amounts of DAPK and ILK were detected in PHN rats ( Figure 5c ). We extended this analysis in MN biopsies and control kidneys (n = 5 in each group).
Quantitative PCR analysis of laser-microdissected glomeruli showed that DAPK and ILK transcript levels were significantly increased in MN when compared with controls (DAPK: 1.62 ± 0.12 versus 1.18 ± 0.06, p<0.05; ILK 1.52 ± 0.13 versus 1.14 ± 0.14, p<0.05) (Figure 5d ). Immunohistochemistry analysis suggests that abundance of both proteins was also increased with a more diffuse pattern for ILK ( Figure   5e ). Altogether, these results suggest that c-mip overexpression alters both integrin-mediated cell-matrix interaction and the regulation of prosurvival signals.
Cyclosporine therapy inhibits c-mip expression and reduces proteinuria in Heymann nephritis
To assess the influence of cyclosporine in this model, PHN rats displaying nephrotic proteinuria were separated in two groups: the one was treated intraperitoneally by cyclosporine at 20 mg/kg daily (CsA group) from the day 21 post-first immunization, while the control group received the vehicle (sodium chloride). Proteinuria was analyzed every three days, between day 21 and day 42. UPr/UCr decreased significantly from the third day-post CsA and reached the nadir at day 38 ( Figure 6a ). In the absence of CsA treatment, proteinuria also decreased over time but remained at nephrotic range in control rats.
Quantitative RT-PCR analysis showed that c-mip abundance was reduced by 50% at day 42, as compared . Although the pathogenesis remains incompletely elucidated, the underlying mechanism involves the generation of antibodies directed against intrinsic podocyte antigens and subsequent formation of subepithelial dense deposits leading to complement activation and glomerular injuries. 1, 3 In this study, we showed that: i) c-mip abundance is significantly increased in human MN; ii) c-mip 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inserm-00815234, version 1 -18 Apr 2013 We have previously shown that c-mip interacts with Fyn, a member of the Src kinase protein family, and prevents its interaction with nephrin, which results in the inhibition of nephrin phosphorylation. This mechanism may explain the downregulation of nephrin phosphorylation found both in minimal change nephrotic syndrome (MCNS) and in c-mip Tg mice. 33, 25 Likewise, it has been reported that nephrin is also hypophosphorylated in MN. 34 In MN and MCNS, the pattern of nephrin expression shifts from linear epithelial to granular interpodocyte filtration slits with changes in cytoskeleton organization, such as seen in c-mip Tg mice. 25 The downregulation of nephrin expression results at least in part from its shedding from the cell surface and its passage to the urinary space. 35 According to previous reports, the onset of proteinuria in PHN does not coincide with the formation of immune complex deposits but with the complement activation-mediated podocyte damage. 14 The mechanism by which the membrane attack of complement (C5b-9) alters nephrin signaling and . According, we show that CsA reduces proteinuria in PHN, in parallel with downregulation Overexpression of c-mip in vitro and in vivo is associated with an increased expression of ILK, a serine/threonine protein kinase involved in the cellular control of integrin-mediated cell-matrix interaction and cell phenotype regulation. ILK contributes to tightly control the interaction of the podocyte cytoskeleton with the matrix components of the glomerular basement membrane (GBM), which is crucial to maintain the complex capillary architecture against the highly transcapillary pressure gradient. Effacement of foot processes and podocyte retraction suggest that molecules at the interface between cytoskeleton and integrin matrix may play a crucial role in these processes. ILK expression is increased in situations associated with an effacement of foot processes, independently of the causal mechanisms, such as congenital nephrosis of Finnish type and adryamicin /puronomycin models of proteinuria. 39, 28 This leads to consider that upregulation of ILK in response to podocyte damage might serve to stabilize the adhesion of unharmed podocytes to GBM, through multiple interactions with cytoskeletal partners. 40 This hypothesis is supported by the fact that ILK is an anti-apoptotic molecule, as opposed to c-mip, which exhibits proapoptotic properties. 
Materials and Methods
Patients.
The cohort of adult patients analyzed in this study has been described in a previous report. 25 Normal renal samples were supplied by the department of pathology, from patients undergoing nephrectomy for polar kidney tumor. PBMC were purified through a Ficoll/Hypaque density gradient (Eurobio, France). All experiments were conducted with approval from the INSERM (Institut National de la Santé et de la Recherche Médicale) research ethics committee in accordance to international ethics codes and guidelines. The informed consent was obtained from all participants involved in this study.
Light microscopy studies and immunohistochemical analyses
In situ hybridization (ISH) experiments using c-mip riboprobes have been previously described. 25 For immunohistochemistry analysis, kidney samples were fixed for 16 hours in Dubosq Brazil, and subsequently dehydrated and embedded in paraffin. Immunofluorescence labeling was carried out on 4-mm thick cryostat sections of kidney tissue fixed in acetone for 10 min, air-dried for 30 min at room temperature, then incubated in PBS for 3 min and blocked in 1% BSA in PBS. The sections were incubated with the indicated antibodies for 1 hour at room 
Northern blots and stable transfections
Total RNA was prepared from glomerular fractions isolated by graded sieving, using Rnaeasy kit (Quiagen, France). Northern blots were performed as previously described (Sahali, 2002 
RhoA and Cdc42 activation assays
Activated RhoA and Cdc42 pull-down kits were purchased from Cytoskeleton (Cytoskeleton, Inc., Denver, USA) and the assays performed following supplied protocols. Briefly, stably transfected podocytes were incubated without or with tetracycline (1 µg/ml) for 48 hours as previously described, then cells were lysed for protein extraction. The protein concentration of lysates was determined by Bradford reaction assay. Equal amount of protein lysates were incubated with Rhotekin-RBD (RhoA assay) or PAK-PBD (Cdc42 assay) affinity beads for 1 hour at 4°C, followed by two washes in lysis 
Induction of passive Heymann Nephritis
PHN was induced in male Lewis rats weighting 100 g by intravenous injection of sheep anti-rat megalin antiserum (kindly provided by Pr Pierre Verroust, INSERM U538, St Antoine Hospital). Two injections at fifteen day's-interval were performed. Twenty rats were injected with anti-megalin antiserum and five control rats received equal volume of normal sheep serum. Individual rats were housed in metabolic cages (Techniplast, France). Urines were collected after 24 hours and this was repeated five times for each individual. Proteinuria was performed using appropriate kits from Advia Chemistry 1650 (Bayer Healthcare AG, Leverkusen, Germany). Rats were sacrificed between 15 and 28 days following the second injection.
Cyclosporine (CsA) treatment
At day 21 post-first immunization, PHN rats with well established nephrotic proteinuria were separated into two groups (n=5 each). The first one (CsA group) was treated with CsA (Sandimmum 
Laser capture microdissection, reverse transcription and real time quantitative PCR (RT-qPCR)
Serial sections (25 µm-thick rat frozen tissue specimens) were placed on membrane slides (Carl Zeiss MicroImaging). Cresyl violet staining was performed by using a protocol from Zeiss Labs, Munich, Germany. 43 Glomerular structures were selectively dissected using the PALM MicroBeam system (Carl Zeiss). Each rat kidney sample was entirely microdissected, giving around 500 glomeruli from which RNAs were extracted in triplicate (about 170 glomeruli/tube) with PicoPure™ RNA Isolation Kit Biosystem, USA) ). For human kidney biopsy specimens from patients with membranous nephropathy, glomeruli were isolated as previously described. 44 A representative figure of human and rat glomeruli before and after laser microdissection is shown in supplementary material ( Figure S2 ). Reverse transcription (RT) was performed with Maxima First Strand cDNA synthesis Kit (Fermentas). Real time quantitative polymerase chain reaction (qPCR) was performed using the oligonucleotides listed in Table 1 . Samples (2 µl of the RT reaction mixture, corresponding to 10 ng of equivalent total RNA) were amplified in a 20 µl reaction mixture containing 0.5 mM levels of each primer and 1 X Quantitect Sybr Green PCR mix (QIAGEN GmbH, Hilden, Germany). PCR was performed in a Light Cycler 480 apparatus (Roche Diagnostic). The c-mip primers amplified a 176-bp sequence (Table 1) . A standard curve was generated for qPCR by using serial dilutions of linearized pdonr221-c-mip plasmid. The copy number was calculated as described (http://www.uri.edu/research/gsc/resources/cndna.html). PCR was initiated by denaturation at 95°C for 15 min, followed by 32 three-step cycles (95°C for 10 s, 63°C for 30 s, and 72°C for 30 s). A dissociation run (95°C for 5 sec followed by 65°C for one min) was performed at the end of PCR program allowing the generation of melting curve. The relative value for each sample was calculated using LightCycler analysis software. All PCR data were normalized to 18S rRNA expression, to control for variations in RT reactions.
The PCR conditions for ILK and DAPK are shown in Table 1 .
Generation of c-mip transgenic mice
The generation of c-mip transgenic mice has been previously described. 25 All experiments involving animals were conducted in accordance with French laws.
Statistics
The data presented are means ± SD and were prepared with GraphPad Prism software, version 4.0. MannWhitney test was used to evaluate the significance of differences. Values of P < 0.05 were considered significant.
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